Bio Protocol vs WEMIX — how do they compare? Bio Protocol trades at Rp511.73 (market cap Rp1,15T, Rp263,61M 24h volume), while WEMIX trades at Rp4,389 (market cap Rp2,18T, Rp19,3M 24h volume). The key difference: WEMIX is the larger of the two by market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 497,9M / 590M WEMIX (85%) for WEMIX. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and WEMIX for 18 Days on average.
| BIO | WEMIX | |
|---|---|---|
Market Cap | Rp1,15T | Rp2,18T |
Volume (24h) | Rp263,61M | Rp19,3M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 497,9M / 590M WEMIX (85%) |
Typical Hold Time | 16 Days | 18 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
WEMIX is trading at Rp4,387 with a bearish technical signal, showing weak momentum as indicated by moving averages and oscillators. The asset faces resistance near Rp4,582 and support at Rp4,157, with an 85% circulation rate and 18-day average hold time. No major protocol updates or ecosystem news were reported recently, limiting fundamental catalysts.
Overall outlook remains cautious due to bearish technicals and lack of positive developments. Key opportunities include potential rebounds from support levels, but risks involve low liquidity, regulatory uncertainty, and high volatility. Investors should monitor on-chain activity and exchange listings for signs of renewed interest.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →WEMIX3.0 is a decentralized blockchain protocol designed to create an experience-driven and platform-oriented ecosystem for Web3 applications. Its high-performance, EVM-compatible mainnet employs a Stake-based Proof of Authority (SPoA) consensus mechanism, which ensures strong security while allowing for high transaction throughput. Governance is managed on-chain by a council of 40 Node Council Partners, with plans for a multi-phase process aimed at achieving full decentralization.
Read more on WEMIX →